Should journals stop publishing research funded by the drug industry?
The BMJ no longer publishes research funded by tobacco companies. Richard Smith and Peter Gøtzsche say that research funded by drug companies is also flawed and published to encourage sales, but Trish Groves says that the industries are fundamentally different and that moves are afoot to increase integrity
Free full text at: http://www.bmj.com/content/348/bmj.g171
Perhaps somebody could point out how research on non-pharmacological therapies e.g. CBT, GET, etc. isn't without its problems, perhaps using the PACE Trial as an example. Also, there is no yellow card scheme for reporting adverse reactions for such therapies, no central body (cf. FDA, European Medicines Agency) regulating the therapies, etc.